These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32205038)

  • 21. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
    Yu XL; Shu L; Shen XM; Zhang XY; Zheng PF
    Medicine (Baltimore); 2017 Sep; 96(39):e8164. PubMed ID: 28953666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
    Lonardo A; Mantovani A; Lugari S; Targher G
    Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
    Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
    BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population.
    Wei Y; Wang J; Han X; Yu C; Wang F; Yuan J; Miao X; Yao P; Wei S; Wang Y; Liang Y; Zhang X; Guo H; Zheng D; Tang Y; Yang H; He M
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3202. PubMed ID: 31291052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study.
    Zhang Q; Ma X; Xing J; Shi H; Yang R; Jiao Y; Chen S; Wu S; Zhang S; Sun X
    Front Endocrinol (Lausanne); 2021; 12():657856. PubMed ID: 34054728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy.
    Frey S; Patouraux S; Debs T; Gugenheim J; Anty R; Iannelli A
    Surg Obes Relat Dis; 2020 Dec; 16(12):2050-2057. PubMed ID: 32788075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study.
    Kim JY; Lee C; Oh M; Im JA; Lee JW; Chu SH; Lee H; Jeon JY
    Clin Chim Acta; 2016 Jul; 458():12-7. PubMed ID: 27020118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
    Liu CQ; He CM; Chen N; Wang D; Shi X; Liu Y; Zeng X; Yan B; Liu S; Yang S; Li X; Li X; Li Z
    Sci Rep; 2016 Dec; 6():38605. PubMed ID: 27924915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
    Chen S; Guo X; Zhang X; Yu S; Yang H; Jiang M; Sun G; Sun Y
    BMC Cardiovasc Disord; 2015 Jul; 15():65. PubMed ID: 26160405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.
    Zhou X; Li Y; Zhang X; Guan YY; Puentes Y; Zhang F; Speliotes EK; Ji L
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3156. PubMed ID: 30892820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in Obese Nigerians: A Cross-Sectional Study.
    Onyia CP; Asogwa P; Adiri W; Obienu O; Ijoma UN; Nwokediuko SC; Okeke EN
    Niger J Clin Pract; 2024 Mar; 27(3):352-360. PubMed ID: 38528356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
    Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
    Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.
    Zhang J; Li K; Pan L; Teng F; Zhang P; Lin B; Yuan Y; Wei X; Li W; Zhang H
    BMC Gastroenterol; 2021 Mar; 21(1):131. PubMed ID: 33743586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity.
    Man S; Deng Y; Ma Y; Yang X; Wang X; Fu J; Yu C; Lv J; Du J; Wang B; Li L
    Obes Res Clin Pract; 2024; 18(2):109-117. PubMed ID: 38443283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.